Cite
Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)
MLA
Krista L. Lanctôt, et al. “Cost Consequence Analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).” International Psychogeriatrics, Apr. 2023, pp. 1–9. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0ffcbdcf06a86a605c613a294dd1c8d0&authtype=sso&custid=ns315887.
APA
Krista L. Lanctôt, Clara Chen, Ethan Mah, Alex Kiss, Abby Li, Dave Shade, Roberta W. Scherer, Danielle Vieira, Hamadou Coulibaly, Paul B. Rosenberg, Alan J. Lerner, Prasad R. Padala, Olga Brawman-Mintzer, Christopher H. van Dyck, Anton P. Porsteinsson, Suzanne Craft, Allan Levey, William J. Burke, Jacobo Mintzer, & Nathan Herrmann. (2023). Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2). International Psychogeriatrics, 1–9.
Chicago
Krista L. Lanctôt, Clara Chen, Ethan Mah, Alex Kiss, Abby Li, Dave Shade, Roberta W. Scherer, et al. 2023. “Cost Consequence Analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).” International Psychogeriatrics, April, 1–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........0ffcbdcf06a86a605c613a294dd1c8d0&authtype=sso&custid=ns315887.